Patent ID: 7261903

Claim:
A method for treating cardiotoxicity caused by a lipophilic or amphiphilic anesthetic agent, which comprises infusing a lipid emulsion composition intravenously whereby the anesthetic agent permeates the lipid emulsion composition and is withdrawn from the bloodstream, said lipid emulsion comprising soybean oil, an emulsifier, a tonicity modifier, and water, wherein the soybean oil is present in an amount in the range of about 10 to about 30 percent by weight, the water is present in an amount in the range of about 70 to about 90 percent by weight, and the emulsifier is present in an amount in the range of about 1 percent to about 5 percent by weight, wherein said anesthetic agent is selected from the group consisting of bupivacaine, lidocaine, tetracaine, and etidocaine.